XML 16 R2.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current assets    
Cash $ 5,040
Prepaid expenses 421
Total current assets 421 5,040
Property and equipment    
Office and laboratory equipment and leasehold improvements 729,859 729,859
Automobile & Trucks 26,400 26,400
Less: Accumulated depreciation (736,459) (735,139)
Total property and equipment, net 19,800 21,120
Other assets - Deposit 12,000 12,000
TOTAL ASSETS 32,221 38,160
Current liabilities    
Accounts payable 723,670 776,021
Accrued expenses 5,465,433 5,096,781
Notes payable 25,800 25,800
Convertible notes payable, net of discount 266,000 420,500
Loan from shareholder 770,753 770,753
Contingency 880,162 880,162
Current liabilities 8,131,818 7,970,017
Total liabilities 8,131,818 7,970,017
Commitments and Contingencies
Stockholders' deficit:    
Common stock, par value $0.001 per share, 300,000,000 shares authorized, 35,902,602 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively 35,904 35,904
Common stock to be issued 53,572 53,572
Additional paid-in capital 22,568,815 22,568,815
Accumulated deficit (30,783,939) (30,616,199)
Total stockholders' deficit of Genethera, Inc. (8,099,598) (7,931,857)
TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT 32,221 38,160
Series A Preferred Stock [Member]    
Stockholders' deficit:    
Series A preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 10,350 shares to be issued as of March 31, 2019 and December 31, 2018, respectively; Series B preferred stock, par value $0.001 per share, 30,000,000 shares authorized, 26,038,572 shares to be issued as of March 31, 2019 and December 31, 2018, respectively 12 12
Series B Preferred Stock [Member]    
Stockholders' deficit:    
Series A preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 10,350 shares to be issued as of March 31, 2019 and December 31, 2018, respectively; Series B preferred stock, par value $0.001 per share, 30,000,000 shares authorized, 26,038,572 shares to be issued as of March 31, 2019 and December 31, 2018, respectively $ 26,039 $ 26,039